Skip to main content
SpringerLink
Log in

Blood-to-Brain Transfer of Various Oxicams: Effects of Plasma Binding on Their Brain Delivery

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The objective of this work was to assess the influence of binding to plasma proteins and to serum on the brain extraction of four antiinflammatory oxicams.

Methods. The brain extraction of isoxicam, tenoxicam, meloxicam and piroxicam was investigated in rats using the carotid injection technique. Blood protein binding parameters were determined by equilibrium dialysis using human serum, human serum albumin (HSA) and alpha-1-acid glycoprotein (AAG) solutions at various concentrations.

Results. All oxicams had low values of brain extraction, between 19% and 39% when dissolved in serum, i.e. under physiological conditions. Brain efflux rate constants calculated from the wash-out curves were the same in the absence or presence of serum. Brain efflux was inversely related to the polarity of the oxicams, such that the higher their H-bonding capacity, the lower their brain efflux. The free dialyzable drug fraction was inversely related to protein concentration. However, rat brain extraction was always higher than expected from in vitro measurements of the dialyzable fraction.

Conclusions. Except for piroxicam whose brain extraction was partially decreased in the presence of proteins, the serum unbound and initially bound fractions of oxicams both seem available for transfer into the brain. Modest affinities for AAG rule out any related effect. More surprising is the apparent lack of effect on brain transfer of the high-affinity binding to HSA and serum. The enhanced brain uptake of meloxicam in the presence of AAG could be a result of interactions between this globular protein and the endothelial wall.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. B. B. Brodie, H. Kurtz, and L. J. Schanker. J. Pharmacol. Exp. Ther. 130:20–25 (1960).

    PubMed  Google Scholar 

  2. P. Riant, S. Urien, E. Albengres, A. Renouard, and J. P. Tillement. J. Neurochem. 51:421–425 (1990).

    Google Scholar 

  3. W. M. Pardridge, R. Sakiyama, and G. Fierer. J. Clin. Invest. 71:900–908 (1983).

    PubMed  Google Scholar 

  4. R. S. Tsai, P. A. Carrupt, N. El Tayar, Y. Giroud, P. Andrade, F. Brée, and J. P. Tillement. Helv. Chim. Acta 76:842–854 (1993).

    Google Scholar 

  5. P. Luger, K. Daneck, W. Engel, G. Trummlitz, and K. Wagner. Eur. J. Pharm. Sci. 4:175–187 (1996).

    Google Scholar 

  6. W. H. Oldendorf. Am. J. Physiol. 221:1629–1639 (1971).

    PubMed  Google Scholar 

  7. D. Triguero, J. Buciak, and W. M. Pardridge. J. Neurochem. 54:1882–1888 (1990).

    PubMed  Google Scholar 

  8. W. M. Pardridge and E. M. Landaw. J. Clin. Invest. 74:745–752 (1984).

    PubMed  Google Scholar 

  9. S. Urien, E. Albengres, A. Comte, J. R. Kiechel, and J. P. Tillement. J. Cardiovascular. Pharmacol. 7:891–898 (1985).

    Google Scholar 

  10. C. Crone. Acta Physiol. Scand. 58:292–305 (1973).

    Google Scholar 

  11. A. Gavezzotti. J. Am. Chem. Soc. 105:5220–5225 (1983).

    Google Scholar 

  12. H. van de Waterbeemd and B. Testa. In B. Testa (Ed.), Advances in Drug Research, Academic Press, London, 1987, Vol. 16, pp. 87–227.

    Google Scholar 

  13. N. El Tayar, B. Testa, and P. A. Carrupt. J. Phys. Chem. 96:1455–1459 (1992).

    Google Scholar 

  14. P. Vallat, P. Gaillard, P. A. Carrupt, R. S. Tsai, and B. Testa. Helv. Chim. Acta. 78:471–485 (1995).

    Google Scholar 

  15. F. Brée, P. Nguyen, S. Urien, P. Riant, E. Albengres, H. Fenner, and J. P. Tillement. Fundam. Clin. Pharm. 3:267–279 (1989).

    Google Scholar 

  16. F. Brée, P. Nguyen, E. Albengres, S. Urien, P. Riant, P. G. Welling, and J. P. Tillement. Biochem. Pharmacol. 38:753–758 (1989).

    PubMed  Google Scholar 

  17. F. Brée, S. Urien, P. Nguyen, P. Riant, E. Albengres, and J. P. Tillement. Eur J. Drug Metab. Pharmacokin. 15:303–307 (1990).

    Google Scholar 

  18. P. Nguyen. Thèse de l'Université Paris XII (1994).

  19. M. P. Dehouck, P. Jolliet-Riant, F. Brée, J. C. Fruchart, R. Cecchelli, and J. P. Tillement. J. Neurochem. 58:1790–1797 (1992).

    PubMed  Google Scholar 

  20. W. M. Pardridge, D. Triguero, J. Yang, and P. A. Cancilla. J. Pharmacol. Exp. Ther. 253:884–891 (1990).

    PubMed  Google Scholar 

  21. W. H. Oldendorf, S. Hyman, L. Braun, and S. Z. Oldendorf. Science 178:984–988 (1972).

    PubMed  Google Scholar 

  22. E. Albengres, S. Urien, J. Barré, P. Nguyen, F. Brée, P. Jolliet, J. P. Tillement, R. S. Tsai, P. A. Carrupt, and B. Testa. Int. J. Tiss. Reac. 15:125–134 (1993).

    Google Scholar 

  23. J. P. Tillement, S. Urien, P. Chaumet-Riffaud, P. Riant, F. Brée, D. Morin, E. Albengres, and J. Barré. Fundam. Clin. Pharmacol. 2:223–228 (1988).

    PubMed  Google Scholar 

  24. R. Belaiba, P. Riant, S. Urien, F. Brée, E. Albengres, J. Barré, and J. P. Tillement. In P. Baumann, C. B. Eap, W. E. Muller, and J. P. Tillement (Eds.), Alpha-l-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions, and Pharmacology, Alan R. Liss, New York, 1989, pp. 287–305.

    Google Scholar 

  25. P. Riant, F. Brée, S. Urien, C. Hamberger, E. Albengres, and J. P. Tillement. Fundam. Clin. Pharmacol. 4:105–114 (1990).

    PubMed  Google Scholar 

  26. S. Urien, D. Morin, and J. P. Tillement. J. Pharmacol. Exp. Ther. 248:781–785 (1989).

    PubMed  Google Scholar 

  27. S. Oie and Y. H. Yang. J. Pharm. Sci. 77:948–951 (1988).

    PubMed  Google Scholar 

  28. F. E. Curry, J. C. Rutledge, and J. F. Lenz. Am. J. Physiol. 257:H1354–H1359 (1989).

    PubMed  Google Scholar 

  29. B. L. Clarke, J. A. Oka, and P. H. Weige. J. Biol. Chem. 262:17384–17392 (1987).

    PubMed  Google Scholar 

  30. W. M. Pardridge. Steroid hormone transport through blood-brain barrier: methods and concepts. Methods in Neurosciences 22:3–22 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Pharmacologie, Faculté de Médecine PARIS XII, F-, 94010, Créteil, France

    Pascale Jolliet, Nicolas Simon, Francoise Brée, Saïk Urien & Jean-Paul Tillement

  2. Ecole de Pharmacie, Université de Lausanne, CH-, 1015, Lausanne, Switzerland

    Alessandra Pagliara, Pierre-Alain Carrupt & Bernard Testa

Authors
  1. Pascale Jolliet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolas Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francoise Brée
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saïk Urien
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessandra Pagliara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pierre-Alain Carrupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bernard Testa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jean-Paul Tillement
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jolliet, P., Simon, N., Brée, F. et al. Blood-to-Brain Transfer of Various Oxicams: Effects of Plasma Binding on Their Brain Delivery. Pharm Res 14, 650–656 (1997). https://doi.org/10.1023/A:1012165414610

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012165414610

Search

Navigation